Stephen Ryan

Dexcom's manufacturing facility in Galway, the completion of Hamburg's 18,000 sq m UKE research building and 4basebio's 37,000 sq ft Cambridge laboratory lease.

TPG's €400 million Project Nightingale acquisition, Trinity by Breakthrough's 214,000 sq ft Oxford completion and Syngenta's $130 million BioSTaR facility in Berkshire.

The Crown Estate's £125 million Oxford life sciences conversion, BfR's 27,500 sq m Berlin lease and a €40 million healthcare portfolio in Dublin.

Remake's €63 million Amsterdam sale-and-leaseback, Flagship Pioneering at King's Cross and Thermo Fisher's €25 million Irish distribution hub

Vectura's €260 million GoCo acquisition, Vetter Pharma's €1.5 billion manufacturing plan and Canary Wharf's landmark lab conversion

Alloga letting at Panattoni Park J28, Kadans and BAM building laboratory at Utrecht Science Park, BioMed Realty completes lease-up at Babraham, and much more.